‘A little company with a big vision’: Temple spinout advancing new way to treat autoimmune disorders

The company, which is already testing a potential psoriasis treatment in humans, received FDA approval to conduct a Phase I trial for its experimental inflammatory liver disease treatment.

Previous Bojangles bringing first Columbus-area restaurant to Hilliard-Rome Road
Next Richmond's Vint raises $5M to create 'asset class' around wine and spirits